tirofiban + oxiracetam

Tirofiban + oxiracetam is a combination of two pharmaceutical agents, each with distinct mechanisms of action. Tirofiban is a non-peptide antagonist of the platelet glycoprotein IIb/IIIa receptor, used primarily as an antiplatelet agent to inhibit platelet aggregation and reduce thrombotic cardiovascular events in acute coronary syndromes. Oxiracetam is a nootropic compound from the racetam family, known for its cognitive-enhancing and neuroprotective effects; it modulates AMPA receptors in the brain to improve memory and cognition. The combination has been investigated in clinical studies for potential synergistic effects, particularly in acute progressive cerebral infarction, but there are no widely approved indications for this specific combination[2][3][6].